| J0897 | Injection, denosumab, 1 mg | 6,000 | $20 | $114K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 950 | $110 | $101K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 1,880 | $30 | $60K |
| J3262 | Injection, tocilizumab, 1 mg | 9,760 | $10 | $48.8K |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 1,360 | $30 | $36.7K |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | 3,500 | $10 | $17.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 110 | $130 | $14.4K |
| 77080 | The provider performs an imaging procedure, called dual–energy X–ray absorptiometry (DXA), of one or more bony areas on the trunk to determine the bone mineral density (BMD) and whether the patient… | 300 | $50 | $13.6K |
| 20611 | In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa, typically the shoulder, hip, knee, or subacromial bursa, and then uses the syringe… | 100 | $120 | $11.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 140 | $70 | $10.2K |